Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) EBITDA: 2012-2025

Historic EBITDA for Phibro Animal Health (PAHC) over the last 14 years, with Jun 2025 value amounting to $110.5 million.

  • Phibro Animal Health's EBITDA rose 189.62% to $51.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.0 million, marking a year-over-year increase of 100.76%. This contributed to the annual value of $110.5 million for FY2025, which is 107.19% up from last year.
  • Latest data reveals that Phibro Animal Health reported EBITDA of $110.5 million as of FY2025, which was up 107.19% from $53.3 million recorded in FY2024.
  • Over the past 5 years, Phibro Animal Health's EBITDA peaked at $110.5 million during FY2025, and registered a low of $53.3 million during FY2024.
  • In the last 3 years, Phibro Animal Health's EBITDA had a median value of $71.8 million in 2023 and averaged $78.5 million.
  • In the last 5 years, Phibro Animal Health's EBITDA fell by 25.79% in 2024 and then surged by 107.19% in 2025.
  • Phibro Animal Health's EBITDA (Yearly) stood at $74.9 million in 2021, then rose by 5.50% to $79.0 million in 2022, then decreased by 9.04% to $71.8 million in 2023, then decreased by 25.79% to $53.3 million in 2024, then spiked by 107.19% to $110.5 million in 2025.